GHOSH ANIRVAN (Chief Executive Officer) sold 0.8% of their position (603.00 shares) of UNITY BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $934.65 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/3/2024ACC: 0000950170-24-052873
DirectorOfficer· Chief Executive Officer
Since Mar 2020
-603.00
Net shares
Net seller
$934.65
Total sold
1
Open market trades
0B · 1S
1
Total transactions
603.00 disposed
Non-Derivative Transactions1
Common Stock, $0.0001 par value
Direct
Shares
−603.00
Price / share
$1.55
Trade value
$934.65
% of position
0.8%
5/2/2024
78.75K→78.14K
Total
Net shares
−603.00
Net value
-$934.65
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Direct | 5/2/2024 | S · Sale | −603.00 | $1.55 | $934.65 | 0.8% | 78.75K | 78.14K |
| Total | −603.00 | -$934.65 | ||||||
Derivative Transactions0
No derivative transactions reported